ABBVIE, INC. for ABBVIE INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trans-Atlantic Trade and Investment Partnership; Trans-Pacific Partnership Agreement; Trade Promotion Authority;
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE DRATZ FERGUSON | — |
| ANDREW KAPLAN | — |
| HEATHER STRAWN | — |
Taxation/Internal Revenue Code TAX
H.R. 4438, American Research and Competitiveness Act of 2014; H.R. 4464, Permanent CFC Look-Through Act of 2014; S. 2260, Expiring Provisions Improvement, Reform, and Efficiency (EXPIRE) Act of 2014; Administrations Tax Reform and 2015 Budget Proposals; Senate and House Committee Tax Reform Proposals; Proposals to reform domestic and international tax structures (no bills introduced); S. 2360, Stop Corporate Inversions Act of 2014; HR 4679, Stop Corporate Inversions Act of 2014; HR 4985, Stop Corporate Expatriation and Invest in Americas Infrastructure Act of 2014; S. 2786, Corporate Inverters Earnings Stripping Reform Act of 2014; H.R. 5549 and S. 2895, Pay What You Owe Before You Go Act; H.R. 4, Jobs for America Act; H.R. 5278 and S. 2704, No Federal Contracts for Corporate Deserters Act;
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| HEATHER STRAWN | — |
| ADELE R WITENSTEIN | — |
Copyright/Patent/Trademark CPT
H.R. 3116, MODDERN Cures Act of 2013; Proposals/Initatives related to international intellectual property protection; S. 1720, Patent Transparency and Improvements Act of 2013; H.R. 3309, Innovation Act; S. 214, Preserve Access to Affordable Generics Act of 2013; H.R. 5750, Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2014
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| HEATHER STRAWN | — |
Health Issues HCR
Discussions and proposals related to the 21st Century Cures initiative; Discussions to clarify or reform the 340B program; Biologics Price Competition and Innovation Act; H.R. 3723, Viral Hepatitis Testing Act of 2013; S. 2538, Viral Hepatitis Testing Act of 2014; Proposals to improve viral hepatitis screening and testing; Public Law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Health Care and Education Reconciliation Act of 2010; Proposals to address prescription drug abuse; Implementation of The Prescription Drug User Fee Act (PDUFA);
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| CATHERINE DRATZ FERGUSON | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| HEATHER STRAWN | — |
| ADELE R WITENSTEIN | — |
Budget/Appropriations BUD
S. 1281, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014; H.R. 3547, Consolidated Appropriations Act, 2014; Other Labor, Health and Human Services Appropriations including increased funding for Viral Hepatitis in President's FY16 Budget; FDAs Changes Being Effected Rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE DRATZ FERGUSON | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| HEATHER STRAWN | — |
Medicare/Medicaid MMM
Policies to enhance patient access to medicines in Medicare; H.R. 2925, Strengthening Medicare Anti-Fraud Measures Act of 2013; S. 117 / H.R. 1102, Medicare Prescription Drug Price Negotiation Act of 2013;
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| HEATHER STRAWN | — |
| ADELE R WITENSTEIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.